| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 4.8K | 10.9% | 33.6% |
| Total Income | 4.8K | 10.6% | 33.5% |
| Expenditure | 4.5K | 11.8% | 36.1% |
| PBT | 356.18 | 7.9% | 17.1% |
| Net Profit | 274.29 | 12.2% | 20.7% |
| OPM | 12.42% | 0.00pp | 0.89pp |
| NPM | 5.70% | 0.08pp | 0.61pp |
| EPS | 19.50 | 12.2% | 20.7% |
Detailed report is being prepared.
Margin Stabilization Test: Can Endurance Deliver ABS Ramp Without Profit Compression?
With Q1 revenue +30% YoY but profit +8% (margin compression alarming), Q2 becomes a margin recovery checkpoint. The Bajaj ABS program kicks off, a new EV plant spins up—but raw material costs threaten near-term profitability despite Street's bullish 15.6% revenue, 17% EPS FY27 consensus.
What Matters in Q2
For an auto-components company in aggressive growth mode, margin stabilization is the only metric that matters to the Street right now. Q1 FY-27 revealed a troubling gap: revenue surged 30% YoY to ₹4,314.89 Cr, but profit growth limped to just 8% (PAT ₹244.52 Cr, -11.6% QoQ). This 22-percentage-point spread between revenue and profit growth signals serious margin compression—likely raw material costs, ABS program startup costs, and capacity underutilization. Q2 is the checkpoint: can Endurance stabilize EBITDA margins while executing the Bajaj dual-channel ABS program (12M units), commissioning the new AURIC Shendra EV casting plant, and integrating recent German acquisitions (Fondalpress, Stöferle expansion)? The Street's bullish FY27 consensus (+15.6% revenue, +17% EPS) depends entirely on margin recovery starting now.
~₹4,200–4,400
Implies 10–12% QoQ growth, or 15–18% YoY if seasonal. Street FY27 consensus at +15.6%; Q1's +30% run-rate unlikely to sustain.
~18–20%
The swing factor. Q1 likely ~18% (compressed from prior 20%+). Stabilization here is the bull thesis; further compression kills FY27 EPS consensus.
~12–15%
On-track to FY27 Street consensus of +17% EPS growth. Requires margin hold above 18% and stable tax rate.
~12M units
High-value, but startup costs depress initial margins. Street expects Q2–Q3 ramp absorption into Q4 margin recovery.
A strong Q2 would show revenue in the ₹4,300–4,400 Cr range (15%+ YoY growth) with EBITDA margin stabilizing at 19–20% (vs Q1's likely 18%), indicating cost/mix headwinds are being absorbed. The Bajaj ABS program launching on schedule (12M units recognized in the quarter) and early validation of the new EV plant's contribution would also reassure. A weak quarter would see revenue growth below 12% YoY, EBITDA margin sliding further below 18%, or any indication that Bajaj ABS ramp costs are pushing profitability deeper into compression. Guidance revision downward would be a red flag; any hint that German acquisition integration or the new EV plant is burning cash faster than expected would also trigger a sharp re-rate.
On Track?
Mixed. Endurance is tracking the revenue side of FY27 guidance solidly: Q1's +30% run-rate (standalone +35.9%) suggests the company could deliver the Street's +15.6% FY27 consensus without strain. However, profit guidance is at risk. The Street's +17% EPS growth target requires PAT to grow faster than revenue from Q2 onwards—which means margins must recover. Q1's +30% revenue / +8% profit math is unsustainable. No explicit FY27 PAT guidance has been issued (the trading window closed Sep 24, which is pre-result protocol), so the Street is inferring expectations from prior calls. What we know: Q1 saw standalone revenue +35.9% YoY with profit growth muted (consolidated +8%), suggesting cost inflation or mix headwinds are real. The Bajaj ABS program is a high-value, but margin-dilutive opportunity near-term (ramp costs). The new EV plant is accretive longer-term but burning cash in Q2–Q3 ramp. Guidance confirmation is the gate: if management guides FY27 PAT growth above 15%, the bull thesis stays intact; below 12% would suggest margin pressure is structural, not temporary.
What the Street Says
Since Last Quarter
1 · European M&A acceleration (€30.34M deployed, Sep–Oct 2026)
Oct 6: Fondalpress SpA acquisition completed for €12.34M (100% stake, Italian brake supplier). Sep 29: Stöferle remaining 32% stake acquisition accelerated for €18M (total Stöferle ownership now 100%, Germany). These two moves consolidate Endurance's European OEM footprint and open higher-margin EV brake/suspension channels. Integration costs will depress Q2–Q3 margins; accretion expected H2 FY27. No red flags in the filings; both are bolt-on roll-ups within Endurance's auto-components DNA.
2 · New EV casting plant commissioned (AURIC Shendra, Sep 25 2026)
Greenfield manufacturing facility at AURIC Shendra, Aurangabad, Maharashtra, has commenced commercial production. Approved with significant capital outlay; expected to serve high-value EV OEM contracts globally. Ramp phase will depress near-term margins (capex depreciation, underutilization); full contribution expected FY28+. This is strategic, but margin-accretive timeline is Q4 FY27 at earliest.
3 · Senior management expansion (Aditya Jhawar, Head - Growth, Sep 10 2026)
Appointed to Senior Management Personnel (elevated role), effective Sep 14. Focus on Growth and Business Transformation. Signals management confidence in FY27–FY28 execution. No red flags; organisational restructuring to support M&A integration and EV ramp is expected.
4 · Insider trading window closed (Oct 1–48h post-result)
Standard SEBI Insider Trading Regulations protocol. Board meeting scheduled Nov 3 to approve Q2 results. FII ownership dipped 0.44pp QoQ to 12.70% (minor selling since Q1); DII steady at 10.06%. Promoter holding stable at 75.00%. No significant pledges or bulk deals flagged; equity ownership structure unchanged.
No material red flags. The M&A activity (€30.34M European capex) and plant commissioning are both strategic and margin-dilutive near-term, which explains raw material cost pressure and startup overhead in Q1. The Street factors this as temporary; but execution delays on ABS program or EV plant ramp would confirm structural margin pressure and trigger re-rating. FII slight selling (0.44pp) is noteworthy but not alarming; likely profit-taking on 26% Q1–Q2 decline rather than fundamental loss of confidence.
What to Watch on Nov 3
1 · Margin stabilization (EBITDA % vs. Q1)
Is Q2 EBITDA margin holding at 18–20%, or slipping further below 18%? This is the fulcrum. If margins hold or improve, the bull thesis lives; if they compress further, Street will flip to 'show me' mode on FY27 profit guidance.
2 · Bajaj ABS ramp detail & contribution
Management commentary on the 12M-unit program launch (in-quarter contribution, revenue, margin profile). Delays or below-plan ramp would suggest execution headwinds. Early success (units shipped on schedule, gross margins above 25%) would support the bull case.
3 · AURIC Shendra and EV plant early traction
Any quantified orders booked, capacity utilization %, or contribution to Q2 revenue? Even symbolic early revenue (₹10–20 Cr) would signal plant ramp is on track. Silent on this would raise questions about demand and utilization.
4 · FY27 PAT guidance or framework
Does management confirm FY27 EPS guidance at Street consensus levels (+17% YoY)? Or do they guide lower / provide a range? This is the gate. If guidance is solid and supported by Q2 margin proof, the ₹2,944 target is defensible; miss, and downside reprices fast.
5 · German acquisition integration progress & cash flow impact
Any quantified integration roadmap, cost savings timeline, or capex/working capital drag from Fondalpress + Stöferle? Street will want to see a path to Q4 accretion, not Q3–Q4 cash burn.
Endurance Technologies is a classic growth-vs.-execution story. The Street loves the top line (30% Q1 growth, +15.6% FY27 guidance, strong Bajaj ABS + EV tailwinds) and the M&A strategy (European consolidation, EV plant). But Q1's margin compression (30% revenue growth / 8% profit growth) has spooked sentiment, sending the stock down 26% from ATH and FII rotating out. The Nov 3 result is margin recovery proof day. If Q2 shows EBITDA stabilizing at 18–20% despite ABS startup costs and European integration, the bull thesis (₹2,944–₹3,435 target, 12% upside) stays in play. But if margins compress further or ABS ramp is delayed, the Street will demand a valuation reset—the 32x FY28 P/E frame assumes flawless execution, which current technicals and insider selling suggest is not consensus.
Three things matter on result day: (1) Q2 EBITDA margin holding steady or improving (vs. Q1's likely 18%), (2) Bajaj ABS 12M-unit program launching on schedule with visible early contribution, and (3) FY27 EPS guidance confirmed at/above ₹80.90 (+17% Street consensus). All three green lights keep the bull story alive and the ₹2,944 target in frame; any crack (margin slip, ABS delays, guidance miss) and the stock reprices sharply lower as the valuation cliff becomes evident.